UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma

Current oncology (Toronto), 2021-11, Vol.28 (6), p.4542-4551

2021

Volltextzugriff (PDF)

Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia

BMC cancer, 2022-02, Vol.22 (1), p.148-148, Article 148

2022

Volltextzugriff (PDF)

Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada

Frontiers in oncology, 2023-12, Vol.13, p.1191920-1191920

2023

Volltextzugriff (PDF)

Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study

Frontiers in oncology, 2023-09, Vol.13, p.1191855-1191855

2023

Volltextzugriff (PDF)

Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade

Current oncology (Toronto), 2023-07, Vol.30 (7), p.6411-6431

2023

Volltextzugriff (PDF)

Nivolumab-Induced Secondary Sclerosing Cholangitis with Deterioration Despite Immunosuppression

Journal of thoracic oncology, 2019-09, Vol.14 (9), p.e205-e206

2019

Volltextzugriff (PDF)

Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment

Cancers, 2020-03, Vol.12 (3), p.650

2020

Volltextzugriff (PDF)

The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach

Frontiers in oncology, 2014, Vol.4, p.178-178

2014

Volltextzugriff (PDF)

Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer

American journal of clinical oncology, 2021-12, Vol.44 (12), p.629

2021

Volltextzugriff (PDF)

Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba

Canadian respiratory journal, 2017-01, Vol.2017, p.7915905-9

2017

Volltextzugriff (PDF)

Cigarette Smoke Decreases Pulmonary Dendritic Cells and Impacts Antiviral Immune Responsiveness

American journal of respiratory cell and molecular biology, 2004-02, Vol.30 (2), p.202-211

2004

Volltextzugriff (PDF)

Benefit of crizotinib in a lung cancer patient with discordant ALK testing results

Cancer treatment and research communications, 2018, Vol.15, p.13-16

2018

Volltextzugriff (PDF)

IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA8505-LBA8505

2023

Volltextzugriff (PDF)

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2023-12, Vol.402 (10419), p.2295-2306

2023

Volltextzugriff (PDF)

Immune Signatures of Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2017-06, Vol.12 (6), p.913-915

2017

Volltextzugriff (PDF)

Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population‐based cross‐sectional study

Cancer, 2024-03, Vol.130 (5), p.740-749

2024

Volltextzugriff (PDF)

Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy

American journal of clinical oncology, 2022-02, Vol.45 (2), p.55

2022

Volltextzugriff (PDF)

The impact of the modified frailty index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy

Journal of geriatric oncology, 2022-06, Vol.13 (5), p.654-661

2022

Volltextzugriff (PDF)

Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study

Canadian journal of public health, 2024-04, Vol.115 (2), p.332-342

2024

Volltextzugriff (PDF)

Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: a systematic review and meta-analysis

Lung cancer (Amsterdam, Netherlands), 2016-09, Vol.99, p.180-185

2016

Volltextzugriff (PDF)

Navigating the Landscape of Translational Geroscience in Canada: A Comprehensive Evaluation of Current Progress and Future Directions

The journals of gerontology. Series A, Biological sciences and medical sciences, 2024-07, Vol.79 (7)

2024

Volltextzugriff (PDF)

Impact of age, comorbidity, and polypharmacy on receipt of systemic therapy in advanced cancers: A retrospective population-based study

Journal of geriatric oncology, 2024-03, Vol.15 (2), p.101689-101689, Article 101689

2024

Volltextzugriff (PDF)

Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

Journal of thoracic oncology, 2023-06, Vol.18 (6), p.813-819

2023

Volltextzugriff (PDF)

Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy

Journal of geriatric oncology, 2021-01, Vol.12 (1), p.112-117

2021

Volltextzugriff (PDF)

Investigating inequalities in cancer staging and survival for adults with intellectual or developmental disabilities and cancer: A population-based study in Manitoba, Canada

Cancer epidemiology, 2024-02, Vol.88, p.102500-102500, Article 102500

2024

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(80)
Humans
(59)
Female
(39)
Male
(35)
Oncology
(30)
Aged
(29)
Aged, 80 And Over
(21)
Adult
(17)
Middle Aged
(16)
Biological And Medical Sciences
(12)
Geriatrics & Gerontology
(12)
Aging
(11)
Animals
(11)
Older People
(11)
Multidisciplinary Sciences
(10)
Science & Technology - Other Topics
(10)
Chemotherapy
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma

Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia

Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada

Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study

Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade

Nivolumab-Induced Secondary Sclerosing Cholangitis with Deterioration Despite Immunosuppression

Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment

The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach

Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer

Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba

Cigarette Smoke Decreases Pulmonary Dendritic Cells and Impacts Antiviral Immune Responsiveness

Benefit of crizotinib in a lung cancer patient with discordant ALK testing results

IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Immune Signatures of Non–Small Cell Lung Cancer

Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population‐based cross‐sectional study

Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy

The impact of the modified frailty index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy

Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study

Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: a systematic review and meta-analysis

Navigating the Landscape of Translational Geroscience in Canada: A Comprehensive Evaluation of Current Progress and Future Directions

Impact of age, comorbidity, and polypharmacy on receipt of systemic therapy in advanced cancers: A retrospective population-based study

Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy

Investigating inequalities in cancer staging and survival for adults with intellectual or developmental disabilities and cancer: A population-based study in Manitoba, Canada

Suchergebnisse filtern